This content is machine translated Multiple sclerosis Better long-term prognosis thanks to modern treatment options Over the past two decades, the arsenal of disease-modifying therapies for multiple sclerosis (MS) has expanded considerably. This applies in particular to the relapsing-remitting form (RRMS), but the treatment options...…
View Post 3 min This content is machine translated Multiple sclerosis Personalized medicine in the focus of treatment management Do we need more therapies? This question is being asked more and more frequently at congresses. The reason for this is the large number of new approvals in recent years.…
View Post 3 min This content is machine translated Alzheimer Early detection and perspectives in therapy management Even though the pathophysiology of Alzheimer’s has not yet been fully identified, it is known that the complex disease manifests itself around 20 years before the first symptoms appear. CSF-based…
View Post 3 min This content is machine translated Multiple sclerosis The effects of biological ageing on disease activity Multiple sclerosis (MS) often takes a progressive clinical course in middle age or later, and the number of older adults with the disease is steadily increasing. Developing new strategies to…
View Post 4 min This content is machine translated Multiple sclerosis Taking a closer look at the challenges of MS research From scientific sessions to topical issues, ECTRIMS addressed the most important questions facing MS and neurological experts today. The program included inspiring keynote speeches from renowned international MS experts as…
View Post 4 min This content is machine translated Multiple sclerosis Predicting and reducing disease activity – what is the current status? Leading experts in the field of neurology met again this year at the world’s largest meeting for research into MS. The focus was on the clinical aspects of the disease,…
View Post 7 min This content is machine translated Multiple sclerosis Current treatment management of relapsing-remitting MS Various therapeutic strategies are available for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologic agents. Although each of these therapies reduces relapse frequency and…
View Post 5 min This content is machine translated Multiple sclerosis Fast, long-lasting, effective – inhibition of alpha4 integrin Relapsing-remitting multiple sclerosis is characterized by the relapsing development of inflammatory lesions in the brain and spinal cord, leading to plaques with demyelination and axonal loss. It is assumed that…
View Post 8 min This content is machine translated Neurology Expecting the unexpected – a look into the future of diagnostics and therapy As the leading association in the field of neurology, the EAN is always striving to do pioneering work by developing new approaches for the meeting and exchange of scientific knowledge.…
View Post 8 min This content is machine translated Neurology News on the management of MS, Alzheimer’s, Parkinson’s, ALS and MG The AAN Annual Meeting is one of the world’s largest gatherings of neurologists. The focus of the exchange is on the latest findings from science and research as well as…
View Post 11 min This content is machine translated Multiple sclerosis Limits, hurdles and solutions in the management of the disease Each year, the Forum of the Americas Committee for Treatment and Research in Multiple Sclerosis explores the dynamic environment of the disease in a unique series of scientific and clinical…
